CA3085067C - Progastrine radiomarquee dans le diagnostic du cancer - Google Patents

Progastrine radiomarquee dans le diagnostic du cancer

Info

Publication number
CA3085067C
CA3085067C CA3085067A CA3085067A CA3085067C CA 3085067 C CA3085067 C CA 3085067C CA 3085067 A CA3085067 A CA 3085067A CA 3085067 A CA3085067 A CA 3085067A CA 3085067 C CA3085067 C CA 3085067C
Authority
CA
Canada
Prior art keywords
cancer
compound
progastrin
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3085067A
Other languages
English (en)
Other versions
CA3085067A1 (fr
Inventor
Jean-Francois Floch
Original Assignee
Ecs-Biotracker Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecs-Biotracker Sarl filed Critical Ecs-Biotracker Sarl
Priority claimed from PCT/EP2018/084172 external-priority patent/WO2019110845A1/fr
Publication of CA3085067A1 publication Critical patent/CA3085067A1/fr
Application granted granted Critical
Publication of CA3085067C publication Critical patent/CA3085067C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne un traceur radioactif comprenant une fraction progastrine, une fraction chélatante et un radio-isotope. L'invention concerne également des utilisations dudit biomarqueur pour l'imagerie et la détection de cancers chez un sujet. Dans un mode de réalisation, le traceur radioactif est la 68Ga-NODAGA-progastrine.
CA3085067A 2017-12-08 2018-12-10 Progastrine radiomarquee dans le diagnostic du cancer Active CA3085067C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762596196P 2017-12-08 2017-12-08
US62/596,196 2017-12-08
PCT/EP2018/084172 WO2019110845A1 (fr) 2017-12-08 2018-12-10 Progastrine radiomarquée dans le diagnostic du cancer

Publications (2)

Publication Number Publication Date
CA3085067A1 CA3085067A1 (fr) 2019-06-13
CA3085067C true CA3085067C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
US12409240B2 (en) Positron emitting radionuclide labeled peptides for human uPAR PET imaging
Xia et al. Comparative evaluation of 68Ga-labelled TATEs: the impact of chelators on imaging
CN110172084A (zh) 68Ga标记NODAGA修饰c-Met分子探针及制备与应用
EP2795317B1 (fr) Composition pour utilisation dans un procédé de sélection des patients
JP2022549258A (ja) セラノスティックスとして使用するための放射性標識ｇｒｐｒアンタゴニスト
AU2018381046B2 (en) Radiolabeled progastrin in cancer diagnosis
CN117120099A (zh) 双模式放射性示踪剂和疗法
CN116730983B (zh) 一种靶向前列腺特异性抗原的化合物及其制备方法与应用
KR20250016195A (ko) 전립선-특이적 막 항원(psma) 리간드
RU2811734C2 (ru) Радиоактивно меченный прогастрин в диагностике рака
US20240050597A1 (en) Radiolabelled alpha-v beta-3 and/or alpha-v beta-5 integrins antagonist for use as theragnostic agent
CN117813326A (zh) 基于放射的导蛋白-1的检测、伴随测试和治疗方法
KR101957416B1 (ko) 암 표적용 화합물 및 이의 용도
KR101957420B1 (ko) 암 표적용 화합물 및 이의 용도
RU2839888C1 (ru) Меченный радиоактивным изотопом антагонист grpr для применения в качестве лечебно-диагностического средства
Verena Development of bispecific prostate-specific membrane antigen/fibroblast activation protein (PSMA/FAP)-targeting radiotracers for prostate cancer imaging
KR20250011145A (ko) 개선된 신장 청소율을 갖는 전립선-특이적 막 항원(psma) 리간드
JP2012042215A (ja) 早期膵がんの検出方法
CN121013861A (zh) 具有生物分布调节剂的抑胃肽受体配体
CN121335717A (zh) 用于治疗碳酸酐酶ix阳性疾病的方法的放射性标记化合物
CN103275188A (zh) 放射性标记t140类多肽化合物及其制备方法和应用
Kersemans SYNTHESIS, IN VITRO/IN VIVO EVALUATION OF 2-IODO-L-PHENYLALANINE AND ITS D-ISOMER AS TUMOUR TRACERS IN ONCOLOGY.
HK1196006A (en) Radiolabelled octreotate analogues as pet tracers